Establishing a new methodology for monitoring of antimicrobial resistance and use in the community in a resource poor setting

Journal of Applied Therapeutic Research

Volumn 7, Issue 2, 2009, Pages 37-45

  Wattal, C ^a   Raveendran, R ^a   Kotwani, A ^b   Sharma, A ^c   Bhandari, S K ^a   Sorensen, T I ^d   Holloway, K ^d  

^a SIR GANGA RAM HOSPITAL   (India)

^b UNIVERSITY OF DELHI   (India)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antimicrobial drug use; Antimicrobial resistance; Commensal E. coli; Surveillance methodology in community; Time series analysis; Urine culture

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFIXIME; CEFPODOXIME PROXETIL; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNITY; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; FEMALE; HUMAN; INDIA; INTERVIEW; METHODOLOGY; MONITORING; OUTPATIENT; PHARMACY; PRENATAL PERIOD; PRIORITY JOURNAL; REPRODUCIBILITY; URINALYSIS;

EID: 77958033730     PISSN: 10292659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Acar J, Kaplan E and O'Brien TF. (1997). Monitoring and management of bacterial resistance to antimicrobial agents: a World Health Organization Symposium. Clinical Infectious Diseases, 24 (Suppl 1): S1-176.
2. Andrasevic AT, Tambic T, Kalenic S and Jankovic V and the working group of the Croatian Committee for antibiotic resistance surveillance. (2002). Surveillance for antimicrobial resistance in Croatia. Emerging Infectious Diseases, 8:14-18.
3. Bartoloni A, Benedetti M, Pallecchi L, Larsson M, et al. (2006). Evaluation of a rapid screening method for detection of antimicrobial resistance in the commensal microbiota of the gut. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100:119-125.
4. Bauer AW, Kirby WM, Sherris JC and Turck M. (1966). Antibiotic susceptibility testing by a standardised single disk method. American Journal of Clinical Pathology, 45:493-6.
5. Centers for Disease Control. (2001). Updated guidelines for evaluating public health surveillance systems. MMWR Morbidity and Mortality Weekly Report, 50:1-35. Available online at www.cdc.gov/mmwr/mmwr-rr.html
6. Collee JG, Miles RS and Watt B. (1996). Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, Eds. Mackie and McCartney practical medical microbiology, 14th ed. London. Churchill Livingstone, pp. 131-49.
7. Hull RA and Hull SI. (1997). Nutritional requirements for growth of uropathogenic E. coli in human urine. Infection and Immunity, 65:1960-1961.
8. Kotwani A, Holloway K, and Roy Chaudhury R. (2009). Methodology for surveillance of antimicrobial use among outpatients in Delhi. Indian Journal of Medical Research, 129:555-560.
9. Lester SC, del Pilar Pla M, Wang F et al. (1990). The carriage of E. coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. New England Journal of Medicine, 323(5):285-289.
10. Melo-Cristino, JL Santos, and M. Ramirez. (2006). The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. Revista Portuguesa de Pneumologia, 12(1):9-30
11. Murray BE, Mathewson JJ, DuPont HL et al. (1990). Emergence of resistant Faecal E. coli in travelers not taking prophylactic antimicrobial agents. Antimicrobial Agents and Chemotherapy, 34:515-518.
12. NCCLS (2002) Performance Standards for Antimicrobial Disk Susceptibility Testing, Wayne, Pennsylvania, USA
13. Okeke IN, Laxminarayan R, Bhutta Z et al. (2005). Antimicrobial resistance in developing countries. Part I: recent trends and status. Lancet Infectious Diseases, 5:481-93. (Pubitemid 41022024)
14. Song JH, Oh WS, Kan CI, Chung DR, et al. (2008). Epidemiology and clinical outcomes of community acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. International Journal of Antimicrobial Agents, 31(2):107-14.
15. Wagner AK, Soumerai SB, Zhang F and Ross-Degnan D. (2002). Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics, 27:299-309.
16. World Health Organization. How to investigate drug use in health facilities. Action programme on essential drugs. 1993. Available at: http://www.who.int/medicinedocs/index. fcgi?a=d&d=Js2289e Accessed February 13, 2008.
17. World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). Norway: WHO, 2004. Available at http://www.who.int/classifications/atcddd/en/Accessed February 16, 2009.
18. WHO collaborative centre for drug statistics methodology. ATC index 2009. Available at http://www.whocc.no/atcddd/Accessed February 16, 2009.